日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Effect of Chronic Social Defeat Stress on the Small-Intestinal Environment, Including the Gut Flora, Immune System, and Mucosal Barrier Integrity

慢性社会挫败应激对小肠环境(包括肠道菌群、免疫系统和黏膜屏障完整性)的影响

Yagi, Soichi; Fukui, Hirokazu; Shiraishi, Tetsuya; Kaku, Koji; Wakita, Midori; Takagi, Yasuhiro; Ikenouchi, Maiko; Sato, Toshiyuki; Kawai, Mikio; Yokoyama, Yoko; Takagawa, Tetsuya; Tomita, Toshihiko; Kitaoka, Shiho; Shinzaki, Shinichiro

Propensity score-matched real-world comparative treatment outcomes of Janus kinase inhibitors for ulcerative colitis in patients with and without prior exposure to anti-tumor necrosis factor α antibody

倾向评分匹配的真实世界比较研究:Janus激酶抑制剂治疗溃疡性结肠炎患者(既往接受过抗肿瘤坏死因子α抗体治疗和未接受过抗肿瘤坏死因子α抗体治疗)的疗效

Ikenouchi, Maiko; Fukui, Hirokazu; Yagi, Soichi; Nogami, Akira; Kaku, Koji; Sato, Toshiyuki; Kawai, Mikio; Kamikozuru, Koji; Yokoyama, Yoko; Takagawa, Tetsuya; Tomita, Toshihiko; Kobayashi, Taku; Shinzaki, Shinichiro

Continuous Treatment with Tofacitinib but Not Filgotinib Is Effective in Non-Responders with Active Ulcerative Colitis: A Propensity Score-Matching Analysis

托法替尼持续治疗而非菲戈替尼持续治疗对无应答的活动性溃疡性结肠炎患者有效:倾向评分匹配分析

Yagi, Soichi; Fukui, Hirokazu; Ikenouchi, Maiko; Shiraishi, Tetsuya; Kaku, Koji; Wakita, Midori; Takagi, Yasuhiro; Sato, Toshiyuki; Kawai, Mikio; Kamikozuru, Koji; Yokoyama, Yoko; Takagawa, Tetsuya; Tomita, Toshihiko; Shinzaki, Shinichiro

Comparative Effectiveness of Ustekinumab and Vedolizumab as Maintenance Therapy After Tacrolimus-Induced Improvement in Patients with Acute Severe Ulcerative Colitis: A Retrospective Cohort Study

乌司奴单抗和维多珠单抗作为他克莫司治疗后急性重症溃疡性结肠炎患者维持治疗的疗效比较:一项回顾性队列研究

Kaku, Koji; Sato, Toshiyuki; Takeuchi, Jiro; Yokoyama, Keiko; Yagi, Soichi; Takagi, Yasuhiro; Ikenouchi, Maiko; Kawai, Mikio; Kamikozuru, Koji; Yokoyama, Yoko; Takagawa, Tetsuya; Tomita, Toshihiko; Fukui, Hirokazu; Shinzaki, Shinichiro

Rationale and Design of the ESPIAL Trial - A Prospective, Randomized, Exploratory Study to Evaluate the Effect of Esaxerenone on Reduction of Urinary Albumin to Creatinine Ratio in Hypertensive Patients Concomitant With Heart Failure and Albuminuria

ESPIAL试验的原理和设计——一项前瞻性、随机、探索性研究,旨在评估依沙沙酮对伴有心力衰竭和蛋白尿的高血压患者尿白蛋白/肌酐比值降低的影响

Suna, Shinichiro; Matsumoto, Yuki; Niki, Katsuyuki; Asanuma, Hiroshi; Higuchi, Yoshiharu; Yasumura, Yoshio; Kawarabayashi, Takahiko; Izumi, Masahiro; Okuhara, Yoshitaka; Hasegawa, Shinji; Goda, Akiko; Ueda, Yasunori; Maruyama, Takao; Sakata, Yasushi; Okumura, Yasuo; Igeta, Masataka; Takagawa, Tetsuya; Asakura, Masanori; Ishihara, Masaharu

Real-world NUDT15 genotyping and thiopurine treatment optimization in inflammatory bowel disease: a multicenter study

真实世界中 NUDT15 基因分型和硫嘌呤治疗优化在炎症性肠病中的应用:一项多中心研究

Makuuchi, Motoki; Kakuta, Yoichi; Umeno, Junji; Fujii, Toshimitsu; Takagawa, Tetsuya; Ibuka, Takashi; Miura, Miki; Sasaki, Yu; Takahashi, Sakuma; Nakase, Hiroshi; Kiyohara, Hiroki; Tominaga, Keiichi; Shimodaira, Yosuke; Hiraoka, Sakiko; Ueno, Nobuhiro; Yanai, Shunichi; Yoshihara, Takeo; Kakimoto, Kazuki; Matsuoka, Katsuyoshi; Hayashi, Ryohei; Nanjo, Sohachi; Iwama, Itaru; Ishiguro, Yoh; Chiba, Hirofumi; Endo, Katsuya; Kagaya, Takashi; Fukuda, Tomohiro; Sakata, Yasuhisa; Kudo, Takahiro; Takagi, Tomohisa; Takahashi, Kenichi; Naganuma, Makoto; Shinozaki, Masaru; Ogata, Noriyuki; Tanaka, Hiroki; Narimatsu, Kazuyuki; Miyazaki, Haruka; Ishige, Takashi; Onodera, Motoyuki; Hashimoto, Yu; Nagai, Hiroshi; Shimoyama, Yusuke; Naito, Takeo; Moroi, Rintaro; Shiga, Hisashi; Kinouchi, Yoshitaka; Andoh, Akira; Hisamatsu, Tadakazu; Masamune, Atsushi

NUDT15 codon 139 is the best pharmacogenetic marker for predicting thiopurine-induced severe adverse events in Japanese patients with inflammatory bowel disease: a multicenter study

NUDT15 密码子 139 是预测日本炎症性肠病患者硫嘌呤类药物诱发严重不良事件的最佳药物遗传学标志物:一项多中心研究

Kakuta, Yoichi; Kawai, Yosuke; Okamoto, Daisuke; Takagawa, Tetsuya; Ikeya, Kentaro; Sakuraba, Hirotake; Nishida, Atsushi; Nakagawa, Shoko; Miura, Miki; Toyonaga, Takahiko; Onodera, Kei; Shinozaki, Masaru; Ishiguro, Yoh; Mizuno, Shinta; Takahara, Masahiro; Yanai, Shunichi; Hokari, Ryota; Nakagawa, Tomoo; Araki, Hiroshi; Motoya, Satoshi; Naito, Takeo; Moroi, Rintaro; Shiga, Hisashi; Endo, Katsuya; Kobayashi, Taku; Naganuma, Makoto; Hiraoka, Sakiko; Matsumoto, Takayuki; Nakamura, Shiro; Nakase, Hiroshi; Hisamatsu, Tadakazu; Sasaki, Makoto; Hanai, Hiroyuki; Andoh, Akira; Nagasaki, Masao; Kinouchi, Yoshitaka; Shimosegawa, Tooru; Masamune, Atsushi; Suzuki, Yasuo

NUDT15, FTO, and RUNX1 genetic variants and thiopurine intolerance among Japanese patients with inflammatory bowel diseases.

NUDT15、FTO 和 RUNX1 基因变异与日本炎症性肠病患者的硫嘌呤不耐受性

Sato Toshiyuki, Takagawa Tetsuya, Kakuta Yoichi, Nishio Akihiro, Kawai Mikio, Kamikozuru Koji, Yokoyama Yoko, Kita Yuko, Miyazaki Takako, Iimuro Masaki, Hida Nobuyuki, Hori Kazutoshi, Ikeuchi Hiroki, Nakamura Shiro

Resolvin E1, an endogenous lipid mediator derived from eicosapentaenoic acid, prevents dextran sulfate sodium-induced colitis

Resolvin E1 是一种源自二十碳五烯酸的内源性脂质介质,可预防葡聚糖硫酸钠诱导的结肠炎。

Ishida, Tsukasa; Yoshida, Masaru; Arita, Makoto; Nishitani, Yosuke; Nishiumi, Shin; Masuda, Atsuhiro; Mizuno, Shigeto; Takagawa, Tetsuya; Morita, Yoshinori; Kutsumi, Hiromu; Inokuchi, Hideto; Serhan, Charles N; Blumberg, Richard S; Azuma, Takeshi

Gamma interferon produced by antigen-specific CD4+ T cells regulates the mucosal immune responses to Citrobacter rodentium infection

由抗原特异性CD4+ T细胞产生的γ干扰素调节对鼠柠檬酸杆菌感染的黏膜免疫反应。

Shiomi, Hideyuki; Masuda, Atsuhiro; Nishiumi, Shin; Nishida, Masayuki; Takagawa, Tetsuya; Shiomi, Yuuki; Kutsumi, Hiromu; Blumberg, Richard S; Azuma, Takeshi; Yoshida, Masaru